基于扫描的竞争性死亡风险模型用于重新评估肺癌CT筛查资格
最终CD模型在衍生队列和验证队列的AUC分别为0.744和0.744,优于外部预扫描模型;结合肺癌发病风险提出的风险阈值可识别出低肺癌风险但高CD风险的亚组,该亚组每检出1例肺癌需筛查人数远高于其余人群,且CD与肺癌病例比值更高。结论提示扫描后同时评估肺癌与CD风险可能提高肺癌筛查效率并促进多学科管理。
要点
- 基于CT信息的竞争性死亡风险模型在衍生和验证队列中AUC均为0.744。
- 结合肺癌发病风险可识别出低肺癌风险高竞争性死亡风险的亚组。
- 该亚组每检出1例肺癌需筛查人数显著高于其余人群,提示可减少筛查。
核心结论
- 扫描后同时评估肺癌风险和竞争性死亡风险可能提高肺癌筛查效率,并促进特定参与者的多学科管理路径。
研究设计与样本
- 使用意大利多中心肺癌检测(MILD)数据(n=2287)进行外部验证。
主要发现
- 最终CD模型在衍生队列的AUC为0.744(95%CI 0.727-0.761),外部预扫描模型CD Risk Assessment Tool的AUC为0.677(95%CI 0.658-0.695)。
- 在验证队列中,最终CD模型AUC为0.744(95%CI 0.652-0.835),外部预扫描模型AUC为0.725(95%CI 0.633-0.816)。
- 验证队列中亚组(774/2287,34%)的每检出1例肺癌需筛查人数为129(其余为29),CD与肺癌病例比值为1.67(其余为0.43)。
关键数值与推荐
- 竞争性死亡风险模型预测5年CD风险,在衍生队列AUC 0.744(95%CI 0.727-0.761),验证队列AUC 0.744(95%CI 0.652-0.835)。
- 外部预扫描模型CD Risk Assessment Tool在衍生队列AUC 0.677(95%CI 0.658-0.695),验证队列AUC 0.725(95%CI 0.633-0.816)。
- 验证队列亚组774/2287(34%),每检出1例肺癌需筛查人数129(其余29),CD/肺癌比值1.67(其余0.43)。
临床怎么用
- 对于CT筛查发现的低肺癌风险但高竞争性死亡风险参与者,可考虑减少肺癌筛查频率并加强心脏和呼吸专科临床投入。
- 扫描后联合评估肺癌风险与竞争性死亡风险有助于优化筛查资源分配和多学科管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A baseline computed tomography (CT) scan for lung cancer (LC) screening may reveal information indicating that certain LC screening participants can be screened less, and instead require dedicated early cardiac and respiratory clinical input. We aimed to develop and validate competing death (CD) risk models using CT information to identify participants with a low LC risk and a high CD risk. METHODS: Participant demographics and quantitative CT measures of LC, cardiovascular disease and chronic obstructive pulmonary disease were considered for deriving a logistic regression model for predicting 5-year CD risk using a sample from the National Lung Screening Trial (n=15 000). Multicentric Italian Lung Detection data were used to perform external validation (n=2287). RESULTS: Our final CD model outperformed an external pre-scan model (CD Risk Assessment Tool) in both the derivation (area under the curve (AUC) 0.744 (95% CI 0.727-0.761) and 0.677 (95% CI 0.658-0.695), respectively) and validation cohorts (AUC 0.744 (95% CI 0.652-0.835) and 0.725 (95% CI 0.633-0.816), respectively). By also taking LC incidence risk into consideration, we suggested a risk threshold where a subgroup (6258/23 096 (27%)) was identified with a number needed to screen to detect one LC of 216 (versus 23 in the remainder of the cohort) and ratio of 5.41 CDs per LC case (versus 0.88). The respective values in the validation cohort subgroup (774/2287 (34%)) were 129 (versus 29) and 1.67 (versus 0.43). CONCLUSIONS: Evaluating both LC and CD risks post-scan may improve the efficiency of LC screening and facilitate the initiation of multidisciplinary trajectories among certain participants.
引用
- Schreuder A, Jacobs C, Lessmann N, et al. Scan-based competing death risk model for re-evaluating lung cancer computed tomography screening eligibility. Eur Respir J. 2022. PMID: 34649976. doi:10.1183/13993003.01613-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。